ISSN: 2157-7013
+44 1300 500008
Department of Biotechnology, Guangzhou Medical University, Guangzhou, Taiwan
Dr. Tongtong Capponi is a distinguished researcher in the Department of Biotechnology at Guangzhou Medical University (GMU), located in Guangzhou, Guangdong, China. Her work focuses on cellular reprogramming, particularly the development and application of induced pluripotent stem cells (iPSCs) in modern biotechnology. Dr. Capponi explores the transformative impact of iPSCs on research, therapeutic development, and personalized medicine. She discusses how iPSCs, which are generated by reprogramming somatic cells to a pluripotent state, have revolutionized the field by providing a versatile platform for disease modeling, drug discovery, and regenerative therapies.Dr. Capponi's research delves into the methodologies for generating iPSCs, including the use of transcription factors and advanced gene-editing techniques. She examines the challenges associated with ensuring the safety and efficacy of iPSC-derived therapies, such as potential genetic abnormalities and immune rejection. Her work also highlights the ethical advantages of iPSCs over embryonic stem cells, as they circumvent controversies related to embryo destruction.
Perspective
Innovations in Cellular Reprogramming: The Role of iPSCs in Modern Biotechnology
Author(s): Tongtong Capponi*
DOI:
10.35248/2157-7013.24.15.469